Literature DB >> 20346005

Bortezomib for the treatment of refractory Type-1 cryoglobulinaemia.

Gilbert Spizzo, Manfred Mitterer, Eberhard Gunsilius.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20346005     DOI: 10.1111/j.1365-2141.2010.08184.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  The complexity of an overlap type resistant cryoglobulinemia: a case report and review of the literature.

Authors:  Milena Tocut; Ziv Rozman; Alexander Biro; Asher Winder; Amir Tanay; Gisele Zandman-Goddard
Journal:  Clin Rheumatol       Date:  2019-01-10       Impact factor: 2.980

Review 2.  Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review.

Authors:  Emilio Besada; Anders Vik; Wenche Koldingsnes; Johannes C Nossent
Journal:  Int J Hematol       Date:  2013-04-25       Impact factor: 2.490

3.  Resistant type II cryoglobulinaemic vasculitis successfully treated with bortezomib in a patient with SLE.

Authors:  Katherine Dutton; Sinisa Savic; Roger Owen; Edward Vital
Journal:  BMJ Case Rep       Date:  2019-01-04

Review 4.  The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.

Authors:  Dario Roccatello; Savino Sciascia; Daniela Rossi; Laura Solfietti; Roberta Fenoglio; Elisa Menegatti; Simone Baldovino
Journal:  Oncotarget       Date:  2017-06-20

Review 5.  Type I cryoglobulinemic vasulitis with eosinophilia: A case report and literature review.

Authors:  Jingjing Wen; Fang Xu; Min Li; Qiaoling Zhou; Wen Qu; Yiping Liu; Jing Su; Hong Hu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.